|
Sunday, 08/01/2010
|
Two-Stage Bridge Model for Binary Responses with Informative Cluster Size
Xiaoyun Li, Florida State University; Dipankar Bandyopadhyay, Medical University of South Carolina; Stuart R. Lipsitz, Brigham and Women's Hospital; Debajyoti Sinha, Florida State University; Debajyoti Sinha, Florida State University
2:50 PM
|
Two-Stage Adaptive Design for Bioequivalence: Methods and Application
Yi-Lin Chiu, Abbott Global Pharmaceuticals Research and Development; Yannis Jemiai, Cytel Inc.; Charles Locke, Abbott Laboratories; Pralay Senchaudhuri, Cytel Inc.
4:25 PM
|
Exact Two-Stage Designs for Phase II Clinical Trials with Rank-Based Endpoints
Gregory E. Wilding, State University of New York at Buffalo; Guogen Shan, State University of New York at Buffalo; Alan Hutson, State University of New York at Buffalo
4:35 PM
|
|
Monday, 08/02/2010
|
Two-Stage Adaptive Design for Case-Control Genetic Association Studies
Lihan Yan, FDA
9:15 AM
|
Optimal Two-Stage Phase II Design Utilizing Partial Information for Long-Term Endpoints
Bo Huang, Pfizer Inc.; Enayet Talukder, Pfizer Inc.; Neal Thomas, Pfizer Inc.
9:35 AM
|
Two-Stage Designs with Additional Futility Tests for Phase II Clinical Trials with Heterogeneous Patient Populations
Myron N. Chang, University of Florida; Sin-Ho Jung, Duke University
10:05 AM
|
A Two-Stage Hybrid Procedure for Estimating an Inverse Regression Function
Runlong Tang, University of Michigan; Moulinath Banerjee, University of Michigan; George Michailidis, University of Michigan
11:05 AM
|
Bayesian Benchmarking with Applications to Small-Area Estimation
Rebecca Carter Steorts, University of Florida; Ghosh Malay, University of Florida; Gauri Datta, The University of Georgia
2:05 PM
|
Hypothesis Testing of Treatment Policies in Two-Stage Randomization Designs
Xiang Guo, sanofi-aventis (China); Anastasios Tsiatis, North Carolina State University
2:30 PM
|
Estimating Incremental Value in Marker Combinations Using a Two-Stage Study Design
Aasthaa Bansal, University of Washington; Margaret Sullivan Pepe, Fred Hutchinson Cancer Research Center
3:35 PM
|
|
Tuesday, 08/03/2010
|
The Data Dependence in Modeling Rat's Tumor Growth Data
Chong Yau Fu, National Yang Ming University; Yueh-Hsing Ou, Institute of Bioonology in Medicine; Shih-Hua Liu, National Yunlin University of Science and Technology
|
Robust Two-Stage Modeling with Finite Mixture Conditional Distributions
Tingting Zhan, Temple University; Inna Chervoneva, Thomas Jefferson University; Boris Iglewicz, Temple University
9:05 AM
|
Admissibility of Naive Estimator Under LINEX Loss in a Two-Stage Design
AnqiI Sun, University of Florida; Mark Yang, University of Florida
10:05 AM
|
Spline-Based Models for Prediction in Survey Samples
Hui Zheng, Harvard Medical School
11:55 AM
|
A Hybrid Geometric Select-and-Test Design Based on Treatment Failure Time and Toxicity
Peter F. Thall, MD Anderson Cancer Center
2:05 PM
|
Overall FDR Control in a Two-Stage Adaptive Design
Jingjing Chen, Temple University; Sanat K. Sarkar, Temple University
2:20 PM
|
Using Genes as Instrumental Variables in Analyses of Social Network Data
A. James O'Malley, Harvard Medical School; J. Niels Rosenquist, Harvard Medical School; Alan Zaslavsky, Harvard Medical School; Nicholas A. Christakis, Harvard University
2:55 PM
|
Interval Estimation in Two-Stage, Drop-the-Losers Clinical Trials with Flexible Treatment Selection
Dan Neal, University of Florida; George Casella, University of Florida; Mark Yang, University of Florida; Samuel S. Wu, University of Florida
3:05 PM
|
|
Wednesday, 08/04/2010
|
Estimating accuracy of a diagnostic test with verification bias when the number of observed false negatives is small: a Monte Carlo approach
Li Deng, New England College of Optometry
|
On Two-Stage Adaptive Design
Gang Li, Johnson & Johnson; Yining Wang, Johnson & Johnson; Weichung J. Shih, University of Medicine and Dentistry of New Jersey
10:35 AM
|
Time Series Modeling of Official Statistics with Two-Stage Benchmarking
Richard Tiller, Bureau of Labor Statistics; Danny Pfeffermann , Hebrew University
11:50 AM
|
Implementing Two-Stage Interviewing in an RDD Survey
W. Sherman Edwards, Westat; J. Michael Brick, Westat; Royce Park, University of California, Los Angeles Center for Health Policy Research; David Grant, University of California, Los Angeles Center for Health Policy Research
3:05 PM
|
|
Thursday, 08/05/2010
|
Sample Size Determination for Two-Stage Equivalence Test
Mi-Chia Ma, National Cheng Kung University; Shang-Bo Ye, National Cheng Kung University
8:35 AM
|
Study Designs for Evaluating Personal Risk Models
Alice S. Whittemore, Stanford University
9:05 AM
|
Use of Propensity Weights and Categories in a Two-Stage Survey
Pedro Saavedra, ICF Macro; Martin Wulfe, ICF Macro; Daniel Geller, ICF Macro; Lee Harding, ICF Macro; Sheku Kamara, U.S. Department of Agriculture; Ted Macaluso, U.S. Department of Agriculture
10:50 AM
|
Design and Trial Operational Considerations for a Phase II Two-Stage Adaptive Trial
Weili He, Merck & Co., Inc.; Madhuja Mallick, Merck & Co., Inc.; Yevgen Tymofyeyev, Merck & Co., Inc.; James A. Bolognese, Cytel Inc.
10:55 AM
|
|